EU-OPENSCREEN

Therapeutic Approaches: Small Molecules, , Covid-19

Therapeutic Areas of Expertise: Cardiology, Immunology, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Oncology, Virology

Center/Program Highlights:

EU-OPENSCREEN is a multinational, not-for-profit initiative, which
integrates high-capacity screening platforms and chemistry groups across
Europe. The aim of this initiative is to support individual scientists
interested in chemical biology and early drug discovery by providing
open access to HTS platforms and medicinal chemistry groups to
collaboratively develop novel chemical probes and lead compounds.

EU-OPENSCREEN
welcomes biologists, who developed an HTS-amenable assay and are
interested in using our HTS platforms to identify novel bioactive
compounds for their targets of interest. EU-OPENSCREEN also welcomes
chemists who wish to make their compounds available to other biologists
in a regulated, transparent framework. Access to the EU-OPENSCREEN resources is open to international researchers from academia and industry.

EU-OPENSCREEN is committed to the FAIRification of data and operates an open-access European Chemical Biology Database (ECBD).

Sources of Funding: Federal/State

Website

Institutional Affiliation(s):

Address:
Robert-Roessle-Str. 10
Berlin
Berlin, 13125
Germany

Center/Program Start Date: 2018

Number of Employees: 15